Research output per year
Research output per year
Personal profile
Research interests
I am interested in looking at biobehavioral influences on ovarian cancer progression and treatment. Also I am a clinical principal investigator in the Endometrial SPORE project at Washington University. Additonally, I am involved in multiple clinical trials for various gynecologic cancers.
Clinical interests
Gynecologic oncology, endometrial cancer, vulvar carcinoma, cervical cancer, ovarian cancer, adnexal masses, tumors, hysterectomy, ob/gyn, women's health, lymphadenectomy, endometrial adenocarcinomas, cervical intraepithelial neoplasia, laparoscopy, gynecologic malignancies
Fingerprint
Dive into the research topics where Premal Thaker is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Diverse case series of granulomatous peritonitis mimicking advanced ovarian cancer
Furuya, R. L., Rimel, B. J., Tsai, R., Brooks, R. A., Stewart Massad, L., Thaker, P. H. & Pfeifer, J. D., Apr 2025, In: Gynecologic Oncology Reports. 58, 101712.Research output: Contribution to journal › Article › peer-review
Open Access -
Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysis
Alvero, A. B., Wu, S., Farrell, A., Kim, S., Wallbillich, J. J., Winer, I., Morris, R., Spetzler, D., Anderson, M. L., Puccini, A., Jones, N. L., Herzog, T. J., Thaker, P. H., Mor, G. & Gogoi, R. P., Mar 2025, In: Gynecologic oncology. 194, p. 71-79 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcoma
Toboni, M. D., Dinkins, K., Wu, S., Mattox, T., Oberley, M. J., Thaker, P. H., Herzog, T. J., Powell, M. A. & Jones, N., Feb 2025, In: Gynecologic oncology. 193, p. 89-97 9 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study
Haight, P. J., Sanchez, M., Thomas, S. M., Smitherman, C., Cosgrove, C., Bae-Jump, V., Crafton, S., Hacker, K., Ko, E., Krivak, T., Lara, O., Moore, K., Mullen, M. M., Pothuri, B., Thaker, P. H., Washington, C., Arend, R., Corr, B., Duska, L. & Jackson, A. & 4 others, , Mar 2025, In: Gynecologic oncology. 194, p. 98-104 7 p.Research output: Contribution to journal › Article › peer-review
-
Update on safety and feasibility of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer
Duska, L. R., Petroni, G. R., Thaker, P. H., Crane, E. K., Holman, L. L., Armstrong, D. K., Romano, K. & Scalici, J., Feb 15 2025, In: Cancer. 131, 4, e35757.Research output: Contribution to journal › Article › peer-review
Open Access